Nishihara, Yu
Nishimori, Makoto
Sawa, Takuma
Uemura, Koya
Nagai, Shun
Todo, Saki
Oota, Eri
Odajima, Susumu
Takeuchi, Kimikazu
Ichikawa, Yasushi
Kintsu, Masayuki
Yamauchi, Yuki
Shiraki, Hiroaki
Yamashita, Kentaro
Fukuda, Terunobu
Hisamatsu, Eriko
Shimizu, Masatoshi
Hirata, Ken-ichi
Tanaka, Hidekazu
Article History
Received: 8 May 2023
Accepted: 24 August 2023
First Online: 21 September 2023
Declarations
:
: H.T. is a consultant for AstraZeneca plc, Ono Pharmaceutical Company, Limited. Pfizer Inc, Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, and Novartis International AG. H.O is a consultant for Abbott Vascular Japan and Terumo Co. K.H. has received research funding from Daiichi Sankyo Company, Limited, Actelion Pharmaceuticals Japan, Terumo Corporation, Abbott Vascular Japan, Otsuka Pharmaceutical Company, Limited, Kowa Company, Limited, Takeda Pharmaceutical Company Limited, Nihon Medi-Physics Company Limited, Novartis Pharma Company Limited, Bayer Company Limited, Biotronic Japan Company Limited, FUJIFILM Toyama Chemical Company Limited, Medtronic Japan Company Limited, Sysmex Company Limited. The remaining authors have no conflicts of interest to declare.